- Short report
- Open Access
Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever
Virology Journalvolume 9, Article number: 122 (2012)
Crimean Congo hemorrhagic fever (CCHF) is a tick-borne hemorrhagic zoonosis associated with high mortality. Pathogenesis studies and the development of vaccines and antivirals against CCHF have been severely hampered by the lack of suitable animal model. We recently developed and characterized a mature mouse model for CCHF using mice carrying STAT1 knockout (KO).
Given the importance of interferons in controlling viral infections, we investigated the expression of interferon pathway-associated genes in KO and wild-type (WT) mice challenged with CCHF virus. We expected that the absence of the STAT1 protein would result in minimal expression of IFN-related genes. Surprisingly, the KO mice showed high levels of IFN-stimulated gene expression, beginning on day 2 post-infection, while in WT mice challenged with virus the same genes were expressed at similar levels on day 1.
We conclude that CCHF virus induces similar type I IFN responses in STAT1 KO and WT mice, but the delayed response in the KO mice permits rapid viral dissemination and fatal illness.
Crimean-Congo hemorrhagic fever virus (CCHFV) is a Nairovirus of the Bunyaviridae and is the etiological agent of Crimean-Congo hemorrhagic fever (CCHF). The virus is associated with mortality rates from 5 to 70% . The pathogenesis of the disease is largely not understood due the lack of a suitable animal model. We recently described the establishment of an adult mouse model for CCHF using STAT1 knockout (KO) mice. STAT1 KO mice are highly susceptible to the virus and the mouse model exhibits key features seen in human cases of CCHF. Mice lacking interferon responses have been increasingly used as models for other hemorrhagic fever viruses, including the families flaviviridae, filoviridae, arenaviridae, and bunyaviridae [2–8].
Using the STAT1 KO model, we noted the production of high levels of interferon α and β in plasma of infected mice . We hypothesized that, despite the lack of STAT1, this interferon may lead to activation of certain interferon-regulated genes, possibly by signaling through alternative pathways. We used interferon α/β response PCR arrays (SA Biosciences, Frederick, MD) to investigate gene expression changes in the spleen and the liver of KO and wild-type (WT) mice infected with CCHFV at 1, 2 and 3 days post-infection. Experiments were conducted as previously described . Briefly, KO and WT mice were challenged intraperitoneally with 100 PFU of CCHFV strain IbAr 10200. Livers and spleens were harvested on day 1, 2 and 3 post-infection. Gene expression of infected KO and WT mice was compared to mock infected KO and WT mice. Liver and spleen were chosen as they were the tissues that showed histopathological changes and had the highest viral titers . All animal studies were performed in accordance with institutional animal care and use protocols. An overview of all data is provided in Additional file 1: Tables S1 and Additional file 2: Tables S2. We noted modest induction of STAT1 in the KO mice; we attribute this to the incomplete knockout of all exons of the STAT1 gene which leads to production of a non-functional STAT1 protein .
Heat maps were plotted using MATLAB (The Mathworks, Natick, MA). Figure 1A shows that semi-quantitative expression profiles of the majority of genes are consistent between all groups, with two exceptions. The first is the lack of gene upregulation by the KO mice at 1 day post-infection. The second is the lack of significant induction if IFN-α2 and IFN-α4 by the WT animals (box). Gene expression in the liver showed a number of differences in expression pattern compared to that observed in the spleen (Figure 1B). Again, the KO mice did not upregulate many genes at 1 day post infection. However, at days 2 and 3 post-infection, KO mice showed increased numbers of upregulated genes compared to WT mice (boxed).To investigate the upstream transcription factors which may be involved in controlling the observed pattern of gene expression, we used PSCAN , which we have previously used to analyze a number of high-throughput hemorrhagic fever datasets . As expected, the analysis revealed IRF1 and IRF2 as key transcription factors involved in the control of these responses. However, at 1 day post-infection, Egr1 and En1 were identified as enriched transcription factor binding sites in genes downregulated in WT mice, but not KO mice. At 3 days post-infection, NF-κB was implicated in transcriptional upregulation in addition to IRFs 1 and 2, possibly due to the increased levels of TNF-α observed at this time .
We sought to place these findings in a functional immune signaling context. We used Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA) to construct signaling networks on the basis of known interactions. We have previously used this software to define cell signaling changes associated with the arenavirus, Pichindé virus[13–15]. The network following infection of the WT mouse (Figure 2A) was more complex than that seen following infection of the KO mice (Figure 2B). Both networks were built around interferon signaling, however, the network induced in WT mice included other key transcription factors including c-Myc, CREBBP (cAMP-responsive element binding, binding protein), p53 and NF-κB. Taken together, these analyses suggest that a more coordinated cellular response to infection, integrating multiple signaling pathways, is produced early in the WT mouse and is required for protection from lethal disease.
We next characterized the significance of specific cellular functions and pathways during infection (Additional file 3: Figure S1). At 1 day post infection, both groups of mice showed similar significance of antigen presentation and immune cell trafficking in the spleen. However, WT mice showed a greater transcriptional response of genes involved in the inflammatory response, antimicrobial response, gene expression, post-translational modification and protein folding. Analysis of gene expression associated with canonical pathways revealed increased numbers of differentially expressed genes associated with the roles of pattern recognition receptors (PRRs), interferon signaling, interferon response factor activation by PRRs, dendritic cell maturation and PKR induction of the antiviral response in the WT mice at 1 day post-infection. However, by 2 days post-infection, there were no striking differences between the pathway significance profiles between the two groups, suggesting that, by 2 days post-infection, KO mice are responding qualitatively similarly to WT mice.
We next looked at the magnitude and kinetics of expression profiles of individual genes in the spleen (Figure 3). As seen in the heatmaps, the majority of genes showing significant (p < 0.05) expression changes showed a lack of induction in the KO mice at 1 day post-infection. Some genes, such as VEGF, showed a similar pattern of expression between both groups. IFN-α2, α4 and β1 were significantly upregulated in KO mice. Given that KO mice should be defective in signaling downstream of the interferon receptor, it had been predicted that the inability of IFN to induce antiviral gene expression was responsible for pathogenesis. However, an interesting finding is that, by 2 days post-infection, many of the genes associated with upregulation by interferons, such as Mx1, Mx2 and 2’5’ oligoadenylate synthase (OAS) demonstrate high levels of expression.
A similar pattern of expression was also observed in the liver (Figure 4), although the levels of IFN target genes were strikingly higher in KO mice than WT mice for many genes, with fold changes of genes such as adenosine deaminase, CXCL10, guanylate-binding proteins (Gbp)-1 and −2, 2’5’ OAS and the Mx proteins being an order of magnitude higher in KO mice by day 2 post-infection. Taken together, these data suggest that high levels of induction of antiviral genes, such as PKR, Mx1 and 2, Gbp-1 and −2 and 2’5’OAS are insufficient to protect against lethal CCHFV-induced disease in this model.
In this report, we have shown that infection of STAT KO mice with CCHFV leads to induction of many interferon-induced genes associated with the antiviral response, but that this response is delayed compared to infection of WT mice. STAT1 KO mice have been used in a number of studies using a range of pathogens [16–22]. Similar to what we demonstrated here, some of these studies reported STAT1-independent IFN pathway gene expression patterns. A recent study demonstrated that much of the STAT1-independent activity is dependent on STAT2, since mice lacking both STAT1 and STAT2 show susceptibility to dengue virus . Our report is consistent with the observations of STAT1-independent type-I IFN signaling described in this study, with STAT1 being required for an early activation of type-I IFN production and antiviral gene expression. Consistent with our mouse model, several studies showed an increased replication in target tissues most likely due to lack of antiviral state of cells allowing the virus to replicate in more cells compared to the wildtype [17, 18, 22]. Interestingly, we also demonstrated residual STAT1 activity in this study, a phenomenon also described by another group . At this point, it is unclear whether the IFN-dependent gene expression seen in this study arose from STAT1-independent pathways, might have resulted, at least in part, from a small amount of residual STAT1 activity, or if they are induced by another mechanism, e.g., the virus itself or by other cytokines. Further studies in our laboratory will focus on elucidating this mechanism.
Many of the findings described are consistent with our previous report  and provide a basis for these observations. Interestingly, in human cells, the type-I interferon response and the MxA protein in particular have been shown to inhibit the replication of CCHFV [25, 26]. Others have demonstrated with Dugbe virus, closely related to CCHFV, that certain IFN genes such as PKR and MxA are not sufficient for protection in a mouse model . Our data shows that induction of these genes is insufficient for protection against CCHFV. This may reveal species-specific differences, in vitro versus in vivo differences, or could be further evidence that the delay in induction of antiviral genes is critical.
In summary, we have further characterized the STAT1 KO mouse model for CCHFV infection. Given our finding of significant antiviral gene expression, we postulate that, as discussed in our previous characterization of the model, that, while the IFN response is critical in the control of CCHFV, it appears the kinetics of the response, combined with the activation of multiple pathways, is the most important factor in determining the outcome of infection.
Whitehouse CA: Crimean-Congo hemorrhagic fever. Antiviral Res 2004,64(3):145-160.
Bradfute SB, Stuthman KS, Shurtleff AC, Bavari S: A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virol J 2011, 8: 300. 10.1186/1743-422X-8-300
Bray M: The role of the Type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001,82(Pt 6):1365-1373.
Kolokoltsova OA, Yun NE, Poussard AL, Smith JK, Smith JN, Salazar M, Walker A, Tseng CT, Aronson JF, Paessler S: Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection. J Virol 2010,84(24):13063-13067. 10.1128/JVI.01389-10
Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E: Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 2004,78(6):2701-2710. 10.1128/JVI.78.6.2701-2710.2004
Boshra H, Lorenzo G, Rodriguez F, Brun A: A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(−/−) mice upon lethal virus challenge. Vaccine 2011,29(27):4469-4475. 10.1016/j.vaccine.2011.04.043
Lever MS PT, Steward JA, Eastaugh L, Smither SJ, Taylor C, Salguero FJ, Phillpotts RJ: Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β −/− interferon receptor-deficient mice. J Med Microbiol 2012, 61: 8-15. 10.1099/jmm.0.036210-0
Raymond J, Bradfute S, Bray M: Filovirus infection of STAT-1 knockout mice. J Infect Dis 2011,204(Suppl 3):S986-S990. 10.1093/infdis/jir335
Bente DA, Alimonti JB, Shieh WJ, Camus G, Stroher U, Zaki S, Jones SM: Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol 2010,84(21):11089-11100. 10.1128/JVI.01383-10
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, et al.: Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996,84(3):431-442. 10.1016/S0092-8674(00)81288-X
Zambelli F, Pesole G, Pavesi G Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 2009,37(Web Server issue):W247-W252.
Bowick GC, McAuley AJ: Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection. Viruses-Basel 2011,3(5):613-619.
Bowick GC, Fennewald SM, Elsom BL, Aronson JF, Luxon BA, Gorenstein DG, Herzog NK: Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J Virol 2006,80(20):10248-10252. 10.1128/JVI.01384-06
Bowick GC, Fennewald SM, Scott EP, Zhang LH, Elsom BL, Aronson JF, Spratt HM, Luxon BA, Gorenstein DG, Herzog NK: Identification of differentially activated cell-signaling networks associated with Pichinde virus pathogenesis by using systems kinomics. J Virol 2007,81(4):1923-1933. 10.1128/JVI.02199-06
Bowick GC, Spratt HM, Hogg AE, Endsley JJ, Wiktorowicz JE, Kurosky A, Luxon BA, Gorenstein DG, Herzog NK: Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection. J Virol 2009,83(2):687-700. 10.1128/JVI.01281-08
Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD: Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 2001,98(12):6680-6685. 10.1073/pnas.111163898
Meier KC, Gardner CL, Khoretonenko MV, Klimstra WB, Ryman KD: A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog 2009,5(10):e1000614. 10.1371/journal.ppat.1000614
Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E: Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 2005,175(6):3946-3954.
Spath GF, Schlesinger P, Schreiber R, Beverley SM: A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major. PLoS Pathog 2009,5(4):e1000381. 10.1371/journal.ppat.1000381
Pasieka TJ, Lu B, Leib DA: Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J Virol 2008,82(12):6052-6055. 10.1128/JVI.00297-08
Karst SM, Wobus CE, Lay M, Davidson J: Virgin HWt: STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003,299(5612):1575-1578. 10.1126/science.1077905
Kato A, Kiyotani K, Kubota T, Yoshida T, Tashiro M, Nagai Y: Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol 2007,81(7):3264-3271. 10.1128/JVI.02590-06
Perry ST, Buck MD, Lada SM, Schindler C, Shresta S: STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog 2011,7(2):e1001297. 10.1371/journal.ppat.1001297
Pasieka TJ, Collins L, O'Connor MA, Chen Y, Parker ZM, Berwin BL, Piwnica-Worms DR, Leib DA: Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in alphassgamma interferon receptor-deficient mice. PLoS One 2011,6(9):e24018. 10.1371/journal.pone.0024018
Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, Mirazimi A: Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 2004,78(8):4323-4329. 10.1128/JVI.78.8.4323-4329.2004
Andersson I, Lundkvist A, Haller O, Mirazimi A: Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 2006,78(2):216-222. 10.1002/jmv.20530
Boyd A, Fazakerley JK, Bridgen A: Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. J Gen Virol 2006,87(Pt 7):2005-2009.
We thank Dr. Mike Bray for critical reading of the manuscript. This work was funded by the Public Health Agency of Canada; DAB received funding from the Natural Sciences and Engineering Research Council of Canada; GCB is funded by the University of Texas Medical Branch Department of Microbiology & Immunology.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicts of interest to disclose.
DAB conceived the study, DAB and AMA performed experiments, GCB performed data and network analysis, GCB and DAB wrote the manuscript. All authors read and approved the final manuscript.